PMCB — Pharmacyte Biotech Share News
0.000.00%
Last trade - 00:00NASDAQ RESUMED AT 09:43 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:39 AM
U.S. STOCKS ON THE MOVE-Katapult, PharmaCyte Biotech, Fulcrum Therapeutics
Brief: Pharmacyte Biotech Receives U.S. FDA Clinical Hold Letter
Brief: Pharmacyte BiotechS Investigational New Drug Application Placed On Hold By The U.S. FDA
Brief: PharmaCyte Biotech Receives CE Mark For Licensed COVID-19 Molecular Tests
Brief: Pharmacyte Biotech Announces Submission Of Drug Master File To FDA For Co's Pancreatic Cancer Therapy
Brief: Pharmacyte Biotech Enters License Agreement For Covid-19 Diagnostic Kits
Brief: PharmaCyte Biotech files for mixed shelf offering of up to $50 million
White House may boost recreational marijuana enforcement -spokesman (updated)
Brief: Pharmacyte Biotech enters into research and consulting agreements with University of Technology Sydney
Brief: FDA grants orphan drug designation to Nuvilex pancreatic cancer treatment